Search results
11 hours ago · Published 1 Oct 2024, 09:47 PM IST. Foxconn has invested more than $1.4 billion in India as of August 2024. (REUTERS) Taiwanese chipmaking giant Foxconn plans to invest up to ₹ 424 crore in a ...
12 hours ago · According to sources, the investment is for Foxconn-HCL OSAT (Outsourced Semiconductor Assembly And Test) plant to be set up in India. Foxconn earlier invested about Rs 246 crore in the JV through its subsidiary Big Innovation Holdings and further increased the investment amount to Rs 312 crore through Foxconn Hon Hai Technology India Mega Development Private Limited.
16 hours ago · HCL Technologies saw a significant increase in its market capitalization today, adding ₹5,530 crore to its total valuation as the stock climbed 1.13%. Shares of HCL Tech closed at ₹1,816.45, reflecting a gain of ₹20.35 from the previous close. This rise brings HCL Tech’s total market cap to ₹4,92,923.70 crore. The stock opened at ₹1,796.00 […]
12 hours ago · Follow Us. New Delhi, Oct 1 (PTI) Taiwanese electronics manufacturing giant Foxconn will invest up to Rs 424 crore in a semiconductor joint venture it has set up with HCL Group, according to an official note and sources. The iPhone contract manufacturer has purchased a 40 per cent stake in a semiconductor joint venture (JV) for about Rs 312 crore.
1 day ago · The investment is for a new OSAT plant and will create jobs in India. New Delhi, Oct 1 (PTI) Taiwanese electronics manufacturing giant Foxconn will invest up to Rs 424 crore in a semiconductor joint venture it has set up with HCL Group, according to an official note and sources. The iPhone contract manufacturer has purchased a 40 per cent stake ...
12 hours ago · share Taiwanese electronics giant Foxconn is set to inject up to Rs 424 crore into a new semiconductor joint venture with the HCL Group, according to official sources. In a major move, Foxconn has acquired a 40 percent stake in the venture, amounting to around Rs 312 crore, with the potential for further investment up to USD 13.31 million (approximately Rs 112 crore).
3 hours ago · Memantine. Memantine, sold under the brand name Axura among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10][11][8] It is taken by mouth. [10][8] Common side effects include headache, constipation, sleepiness, and dizziness. [10][11] Severe side effects may include blood clots, psychosis, and ...
